The nonprofit said technologies like ChatGPT have suggested incorrect diagnoses, invented body parts and otherwise provided ...

AdvaMed CEO Scott Whitaker and Mick Farrell, new board chair of the trade group, weighed in on important issues for the medtech industry one year into the Trump administration.

Pricing challenges in Abbott’s nutrition business and lower than expected sales of continuous glucose monitors drove down the ...

The assistant, which can answer health questions and help schedule appointments, comes on the heels of other health-focused AI tools from OpenAI and Anthropic.

Medtronic’s investment is contingent on Anteris completing a proposed $200 million public stock offering.

Boston Scientific has told customers to stop using certain stents linked to three deaths, the Food and Drug Administration ...

Abbott’s latest CE mark for its TactiFlex Duo system was based on a clinical trial conducted in the European Union, United ...

Penumbra is expected to give Boston Scientific more of a presence in the vascular surgery market, with little overlap between ...

The company has committed the cash, half of which it is paying upfront, to buy Integrity Orthopaedics for its rotator cuff ...

With the planned purchase, Boston Scientific will gain several thrombectomy devices to remove clots from blood vessels.

Medtronic will integrate Precision Neuroscience’s Layer 7 cortical interface with its StealthStation surgical navigation ...

CEO Dave Rosa said a strong rollout for the da Vinci 5 surgical robot in 2025 exceeded expectations, with the system driving ...